ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0878

A United States Nationwide Analysis of Total Knee Arthroplasty in Patients < 21 Years Old

John Gibbons1, Cynthia A. Kahlenberg1, Deanna Jannat-Khah, DrPH, MSPH1, Alexander B. Christ2, Susan Goodman1, Peter Sculco1, Mark Figgie1 and Bella Mehta3, 1Hospital for Special Surgery, New York, NY, 2Keck School of Medicine of USC, Los Angeles, CA, 3Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

Meeting: ACR Convergence 2022

Keywords: Arthroplasty, Juvenile idiopathic arthritis, Juvenile Inflammatory Arthritis, Orthopedics, Pediatric rheumatology

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: Pediatric Rheumatology – Clinical Poster I: JIA

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Total knee arthroplasty (TKA) is rarely performed in patients under 21 years old and may be performed in this population due to conditions such as inflammatory arthritis or juvenile idiopathic arthritis (JIA), malignant or non-malignant tumor, avascular necrosis, sepsis, trauma, hemophilia, or dysplasia. However, the number of patients < 21 undergoing TKA in the United States (U.S.) is unknown. In one of the largest U.S. studies of an institutional arthroplasty registry, only 19 TKAs were performed in patients < 21 out of ~30,000 primary TKAs over 34 years—a majority of which were for JIA1. The purpose of this study was to evaluate trends in the use of TKA in patients < 21 in the U.S. Additionally, we aimed to determine the epidemiological characteristics and to describe the hospitals in which this procedure is performed.

Methods: We retrospectively analyzed the Kids’ Inpatient Database (KID), a national weighted sample of all inpatient hospital admissions in the U.S. for ~4,200 hospitals in 46 states in patients under 21 years old. We used International Classification of Diseases, Ninth Revision (ICD-9) and ICD-10 codes to identify patients undergoing TKA from 2000 through 2016 and determine primary diagnosis. Descriptive statistics such as means and percentages, along with their 95% confidence intervals (95% CI) were calculated using the appropriate sample weights as recommended by the Agency for Healthcare Research and Quality for use with the KID dataset.

Results: The total weighted number of TKAs performed in patients < 21 from 2000-2016 was 1,331 (Table 1); the number of TKAs performed per year remained relatively stable (Figure 1). The mean age of patients undergoing TKA was 14.8 years (95% CI: 14.4, 15.2), and 48.8% of the cohort was female. Among tumor patients, a higher proportion identified as Hispanic (22.1%) or Other race (12.6%) compared to the non-tumor cohort. 70.3% of TKAs were performed for a primary diagnosis of tumor, and the number of TKAs for malignant tumors has increased slightly over the study period (Figure 2). In contrast, use of TKA for inflammatory arthritis / JIA decreased by over 70% over the study period. The majority of TKAs were performed in urban teaching hospitals and in facilities with a large bed size.

Conclusion: From 2000-2016, the number of TKAs performed per year in patients < 21 years old in the U.S. has remained constant. The majority of TKAs were performed due to tumors and were in urban teaching hospitals with a large bed size, which likely reflects the complexity and rarity of these procedures. While the use of TKA for malignant tumor has increased slightly over the study period, use for inflammatory arthritis / JIA has decreased significantly over the past two decades, likely due to improvements in medical management of inflammatory arthritis / JIA patients.

References
1. Martin JR et al. Adolescent total knee arthroplasty. PMCID: PMC5484984

Supporting image 1

Table 1. Characteristics of patients <21 years old undergoing TKA and hospitals in which TKA is performed

Supporting image 2

Figure 1. Weighted number of TKAs performed in patients <21 years old per year. * U.S. population estimates from the National Center for Education Statistics. Table 100.10. Estimates of resident population, by age group: 1970 through 2019. https://nces.ed.gov/programs/digest/d19/tables/dt19_101.10.asp (accessed 12.05.21).

Supporting image 3

Figure 2. Weighted number of TKAs performed per year for top three primary diagnoses. ** Per HCUP guidelines, data representing ≤ 10 cases have been omitted to protect patient confidentiality


Disclosures: J. Gibbons, None; C. Kahlenberg, None; D. Jannat-Khah, DrPH, MSPH, Cytodyn, AstraZeneca, Walgreens; A. Christ, Smith & Nephew, Intellijoint Surgical; S. Goodman, Novartis, UCB; P. Sculco, None; M. Figgie, Wishbone, Lima, Mekanika, HS2; B. Mehta, None.

To cite this abstract in AMA style:

Gibbons J, Kahlenberg C, Jannat-Khah, DrPH, MSPH D, Christ A, Goodman S, Sculco P, Figgie M, Mehta B. A United States Nationwide Analysis of Total Knee Arthroplasty in Patients < 21 Years Old [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/a-united-states-nationwide-analysis-of-total-knee-arthroplasty-in-patients-21-years-old/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-united-states-nationwide-analysis-of-total-knee-arthroplasty-in-patients-21-years-old/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology